COVID-19 experiences predicting high anxiety and depression among a sample of BRCA1/BRCA2-positive women in the USArticle Published on 2021-12-302022-10-04 Journal: Scientific Reports [Category] 변종, 유전자 메커니즘, [키워드] 95% CI 95% confidence interval Anxiety association Breast cancer can be used cancers CIs COVID-19 COVID-19 pandemic Demographic factors Depression depressive symptom genetics high risk investigated less mental health multivariable logistic regression Odds ratio ovarian cancer pandemic predictor Psychology reported Research resource significantly more similarity stratified survivor women [DOI] 10.1038/s41598-021-04353-x PMC 바로가기 [Article Type] Article
Pfizer-BioNTech COVID-19 Vaccine in Gynecologic Oncology Patients: A Prospective Cohort StudyArticle Published on 2021-12-232022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] adverse effects age BMI boost Cancer Chemotherapy control group COVID-19 COVID-19 vaccine evaluate Gynecologic oncology healthy IgG antibody immunogenic moderate oncology oncology patient ovarian cancer Patient patients Pfizer-BioNTech Prospective prospective cohort study reported Result Safe SARS-CoV-2 the patient vaccination Vaccine women [DOI] 10.3390/vaccines10010012 PMC 바로가기 [Article Type] Article
Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian CancerArticle Published on 2021-11-172023-08-30 Journal: Frontiers in Endocrinology [Category] E형 간염, [키워드] endocrine cancer hypoxia Immunotherapy ovarian cancer tumor microenvironment [DOI] 10.3389/fendo.2021.772349 PMC 바로가기
Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP InhibitorsArticle Published on 2021-10-082022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] anti-SARS-CoV-2 antibody cancer patient co-morbidities Cohort COVID-19 COVID-19 vaccination demographics enrolled General population healthy volunteer Infection inhibitor NAbs ovarian cancer PARP PARP inhibitors Patient Precaution provide receiving reduce response SARS-CoV-2 SARS-CoV-2 immunity SARS-CoV-2 neutralizing antibody second dose significantly lower the patient therapy treated Treatment two groups vaccination [DOI] 10.3390/vaccines9101148 PMC 바로가기 [Article Type] Article
The impact of the COVID-19 coronavirus pandemic on the surgical management of gynecological cancers: Analysis of the multicenter database of the French SCGP and the FRANCOGYN groupObservational Study Published on 2021-10-012022-10-05 Journal: Journal of gynecology obstetrics and human reprodu [Category] SARS, 임상, [키워드] analyzed borderline Borderline tumor Cancer Cancer of vulva cancers Care Cervical cervical cancer change changed changes in Characteristics Chemotherapy Cohort cohort study collected conducted coronavirus coronavirus SARS-CoV-2 COVID-19 COVID-19 pandemic database demographic detrimental Endometrial Cancer France French greater group Gynecologic Health Healthcare system hospital include intensive care units management material median age methodological modify multicenter Observational data observé offered ovarian ovarian cancer pandemic Patient patients Pelvic positive provided representing SARS-CoV-2 Society study period Support surgery surgical surgical treatment tested therapeutic Topic Treatment undergo virus women [DOI] 10.1016/j.jogoh.2021.102133 PMC 바로가기 [Article Type] Observational Study
Factors contributing to treatment delays among Medicaid-insured patients with gynecologic malignancies during COVID-19 in New York CityConference abstract Published on 2021-08-012022-10-05 Journal: Gynecologic oncology [Category] 치료법, [키워드] age Asian average average delay Cancer cancer diagnosis Care Chemotherapy children Clinical characteristics clinician contributing to COVID-19 COVID-19 diagnosis COVID-19 pandemic death determine Diagnosis died disease download eligible patient employment Endometrial Cancer Factor Health Hispanic hospital include individual Intervention majority malignancy New York City occurred oncology oncology patient oncology patients Other ovarian cancer pandemic Patient patients populations Prevent proceed progression of disease Radiation receiving reducing reported resulting risk Surveillance syndrome the median the patient transferred Treatment white [DOI] 10.1016/S0090-8258(21)00766-6 [Article Type] Conference abstract
Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19)Review Published on 2021-06-012023-07-06 Journal: International journal of gynecological cancer : official journal of the [Category] SARS, [키워드] cervical cancer endometrial neoplasms Gynecology ovarian cancer [DOI] 10.1136/ijgc-2020-001942 [Article Type] Review
What is Elective Oncologic Surgery in the Time of COVID-19? A Literature Review of the Impact of Surgical Delays on Outcomes in Patients with CancerArticle Published on 2021-05-302022-10-31 Journal: Clinical oncology and research [Category] COVID-19, [키워드] affected article Breast cancer Cancer cancer patient cancer type Colon cancer consequence COVID-19 COVID-19 pandemic Delay demonstrated Elective expert hepatocellular Impact impacted infected with SARS-CoV-2 literature Melanoma oncology osteosarcoma outcome outcomes ovarian cancer Pancreatic cancer Patient pediatric reduced resources review selected shown Spread stage I surgery surgical surgical delays Surgical oncology survival Thyroid time Time to surgery widespread [DOI] 10.31487/j.COR.2020.06.05 PMC 바로가기 [Article Type] Article
COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreakObservational Study Published on 2021-04-012022-10-05 Journal: Gynecologic oncology [Category] 임상, [키워드] activities activity affected allocation Allocation resources cancer patient Care COVID-19 COVID-19 infection COVID-19 patients death described Gynaecological cancers healthcare high risk Italian Italian region Italy lack lockdown majority material Measures oncology outbreak outcome outcomes ovarian cancer pandemic pathway Patient performed prospective observational study protocols resource SARS-CoV-2 surgical the SARS-CoV-2 unit university were recorded [DOI] 10.1016/j.ygyno.2020.09.030 PMC 바로가기 [Article Type] Observational Study
Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment정량적 단백질체학은 COVID-19 치료에 도움이 되는 이버멕틴의 광범위한 항바이러스 특성을 나타냅니다Article Published on 2021-04-012022-09-11 Journal: Journal of cellular physiology [Category] SARS, 유전자 메커니즘, 치료기술, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 alteration Amino acid amino acids Analysis Antibacterial anticancer Antiviral biological processes Cancer cells Cell Cell culture cells cellular components complex coronavirus COVID-19 COVID-19 treatment cytokine Cytokines cytomegalovirus Diseases EBV Epstein-Barr virus G-protein Gene ontology Gene ontology analysis global public health growth factor HCMV Health HIV HIV1 HLA HPV Human Cytomegalovirus Human immunodeficiency virus human papillomavirus identify immunodeficiency virus IMPROVE in vitro Infection inhibit Interaction Ivermectin labeling molecular functions network analysis offer ovarian cancer papillomavirus pathway Pathways Personalized medicine PPI PPI network Predictive Protein Proteins proteomics Quantitative quantitative proteomics regulated Replication replication of SARS-CoV-2 reported reveal SARS-CoV-2/COVID-19 STABLE stable isotope labeling by amino acids in cell culture statistically significant treated Treatment virus virus infection virus-related pathways. was used [DOI] 10.1002/jcp.30055 PMC 바로가기 [Article Type] Article